Tetraphase Pharmaceuticals, Inc. (TTPH)

[rusty8350]

I really wouldn't think a buyout would be on the table at this point. Big pharma just doesn't usually buy out little companies like this until after they get fda approval.

It's an interesting idea, I just don't see it as being very likely.

If they sold out in the teens, it would be a huge loss for nearly anyone who invested here, as all their public offerings have been at higher prices. With approval of the drug, they would realistically be valued in the billions, and the current market cap here is well below that.

What it looks like to me, is that they're about to offer up some more stock for sale. Did you see the S3 and following notice of effectiveness?

Not sure exactly how or why, but it ALWAYS seems like stocks magically run right before a company is about to dump some more stock and dilute. Sometimes they do this to coincide with good news. In this case, I think they need more money to fully fund all the extra trials they needed to get the approval of eravacycline.



https://www.sec.gov/Archives/edgar/data/1373707/000119312516778155/d278406ds3a.htm